Get Premium to unlock powerful stock data
NAS:CRTX (USA)  
Cortexyme Inc logo

Cortexyme Inc

$ 2.52 +0.3 (+13.51%) 08:08 PM EST
P/E:
At Loss
P/B:
0.71
Market Cap:
$ 91.10M
Enterprise V:
$ -85.00K
Volume:
713.79K
Avg Vol (2M):
535.07K
Volume:
713.79K
Market Cap $:
91.10M
PE Ratio:
At Loss
Avg Vol (2-Month):
535.07K
Enterprise Value $:
-85.00K
PB Ratio:
0.71
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Cortexyme Inc
NAICS : 325412 SIC : 2836
269 East Grand Avenue, South San Francisco, CA, USA, 94080
Description
Cortexyme Inc is a clinical-stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases. Its approach is based on the seminal discovery of the presence of Porphyromonas gingivalis or P. gingivalis, and its secreted toxic virulence factor proteases called gingipains. The company operates in only one reportable segment that is developing and commercializing therapeutics.
Name Current Vs Industry Vs History
Cash-To-Debt 269.98
Equity-to-Asset 0.92
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -78.5
3-Year EPS without NRI Growth Rate -73.5
3-Year FCF Growth Rate -56.6
Name Current Vs Industry Vs History
5-Day RSI 61.21
9-Day RSI 49.18
14-Day RSI 44.34
6-1 Month Momentum % -80.9
12-1 Month Momentum % -95.63

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.92
Quick Ratio 9.92
Cash Ratio 9.43

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5
Name Current Vs Industry Vs History
ROE % -67.44
ROA % -60.39
ROIC % -361.61
ROC (Joel Greenblatt) % -6921.11
ROCE % -67.51

Financials (Next Earnings Date:2022-08-09 Est.)

CRTX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:CRTX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -2.97
Beta 1.35
Volatility % 142.98
14-Day RSI 44.34
14-Day ATR ($) 0.247126
20-Day SMA ($) 2.67
12-1 Month Momentum % -95.63
52-Week Range ($) 2.1235 - 121.98
Shares Outstanding (Mil) 36.15

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cortexyme Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More